Mississippi State University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Mississippi State University sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Mississippi State University: 5 sponsored US clinical trials, 1 recruiting.
Mississippi State University sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hoarding Disorder, with 1 trials.
Upper-quartile sponsor footprint
Mississippi State University sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Motivational Interviewing to Enhance Behavioral Change in Older Adults with Hoarding Disorder
NCT05237466
Accessible Remote Rehabilitation System for Real-Time Biomechanical Monitoring
NCT07492797
Investigating Two Prototype Mobile App Interventions to Increase Physical Activity
NCT06372275
An Initial Test of Prototype Mobile App Interventions for Decluttering
NCT06108245
Healthy Teen Girls: HIV Risk Reduction
NCT00787696
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Therapeutic Areas
What is open in the Mississippi State University pipeline
1 recruiting of 5 indexed (20% open); 3 completed (60%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Hoarding Disorder (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Mississippi State University: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Mississippi State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Mississippi State University page
5 registered trials is a research-attention snapshot, not an endorsement of Mississippi State University or any single study.
- 1 of Mississippi State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hoarding Disorder is the condition Mississippi State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hoarding Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Mississippi State University pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.